Gadducci et al: Treatment planning in endometrial cancer Hirai Y, Takeshima N, Kato T, Hasumi K. (2001) Malignant potential of positive peritoneal cytology in endometrial cancer. Obstet Gynecol 97, 725-728. Hoffman MS, Roberts WS, Cavanagh D, Praphat H, Solomon P, Lyman GH. (1989) Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide, and megestrol acetate. Gynecol Oncol 35, 75-77. Holloway RW. (2003) Treatment options for endometrial cancer: experience with topotecan. Gynecol Oncol 90, S28-33. Holub Z, Jabor A, Bartos P, Eim J, Urbanek S, Pivovarnikova R. (2002) Laparoscopic surgery for endometrial cancer: longterm results of a multicentric study. Eur J Gynaecol Oncol 23, 305-310. Horton J, Begg CB, Arseneault J, Bruckner H, Creech R, Hahn RG. (1978) Comparison of adriamycin with cyclophosphamide in patients with advanced endometrial cancer. Cancer Treat Rep. 62, 159-161. Hoskins PJ, Swenerton KD, Pike JA, Wong F, Lim P, AcquinoParsons C, Lee N. (2001) Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study. J Clin Oncol 19, 4048-4053. Jeyarajah AR, Gallagher CJ, Blake PR, Oram DH, Dowsett M, Fisher C, Oliver RT. (1996) Long-term follow-up of gonadotrophin-releasing hormone analog treatment for recurrent endometrial cancer . Gynecol Oncol 63, 47-52. Jhingran A, Burke TW, Eifel PJ. (2003) Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. Int J Radiat Oncol Biol Phys 56, 1366-1372. Kadar N, Homesley HD, Malfetano JH. (1992) Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease. Gynecol Oncol 46, 145-149. Kasamatsu T, Onda T, Katsumata N, Sawada M, Yamada T, Tsunematsu R, Ohmi K, Sasajima Y, Matsuno Y. (2003) Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus. Br J Cancer 88, 245-250. Kashimura M, Sugihara K, Toki N, Matsuura Y, Kawagoe T, Kamura T, Kaku T, Tsuruchi N, Nakashima H, Sakai H. (1997) The significance of peritoneal cytology in uterine cervix and endometrial cancer. Gynecol Oncol 67, 285-290. Kauppila A. (1984) Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations. Acta Obstet Gynecol Scand 63, 441-450. Kennedy AW, Webster KD, Nunez C, Bauer LJ. (1993) Pelvic washings for cytologic analysis in endometrial adenocarcinoma. J Reprod Med 38, 637-642. Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, Noojin F 3rd, Conner W. (1995) Adenocarcinoma of the endometrium, survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 56, 29-33. Kline RC, Freedman RS, Jones LA, Atkinson EN. (1987) Treatment of recurrent or metastatic poorly differentiated adenocarcinoma of the endometrium with tamoxifen and medroxyprogesterone acetate. Cancer Treat Rep 71, 327328. la Vecchia C, Franceschi S, Parazzini F, Colombo E, Colombo F, Liberati A, Mangioni C. (1983) Ten-year survival in 290 patients with endometrial cancer, prognostic factors and therapeutic approach. Br. J Obstet Gynaecol. 90, 654-661. Lanciano RM, Corn BW, Schultz DJ, Kramer CA, Rosenblum N, Hogan WM. (1993) The justification for a surgical staging system in endometrial carcinoma. Radiother. Oncol 28, 189-196. Langebrekke A, Istre O, Hallqvist AC, Hartgill TW, Onsrud M. (2002) Comparison of laparoscopy and laparotomy in
patients with endometrial cancer. J Am Assoc Gynecol Laparosc 9, 152-157. Larson DM, Broste SK, Krawisz BR. (1998) Surgery without radiotherapy for primary treatment of endometrial cancer. Obstet Gynecol 91, 355-359. Le TD, Yamada SD, Rutgers JL, DiSaia PJ. (1999) Complete response of a stage IV uterine papillary serous carcinoma to neoadjuvant chemotherapy with taxol and carboplatin. Gynecol Oncol 73, 461-463. Lee KR, Belinson JL. (1991) Recurrence in noninvasive endometrial carcinoma. Relationship with uterine papillary serous carcinoma. Am J Surg Pathol 15, 965-973. Lee SW, Russell AH, Kinney WK. (2003) Whole abdomen radiotherapy for patients with peritoneal dissemination of endometrial adenocarcinoma. Int J Radiat Oncol Biol Phys 56, 788-792. Levin L, Hryniuk W. (1987) The application of dose intensity to problems in chemotherapy of ovarian and endometrial cancer. Semin Oncol 14 (Suppl 4), 12-19. Lincoln S, Blessing JA, Lee RB, Rocereto TF. (2003) Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 88, 277-281. Lissoni A, Zanetta G, Losa G, Gabriele A, Parma G, Mangioni C. (1996) Phase II study of paclitaxel as salvage treatment in advanced endometrial cancer. Ann. Oncol 7, 861-863. Long HJ, Pfeifle DM, Wieand HS, Krook JE, Edmonson JH, Buckner JC. (1988) Phase II evaluation of carboplatin in advanced endometrial carcinoma. J Natl. Cancer Inst. 80, 276-278. Lovecchio JL, Averette HE, Lichtinger M, Townsend PA, Girtanner RW, Fenton AN. (1984) Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-platinum, and megestrol acetate. Obstet Gynecol 63, 557-560. Luo ML, Sakuragi N, Shimizu M, Seino K, Okamoto K, Kaneuchi M, Ebina Y, Okuyama K, Fujino T, Sagawa T, Fujimoto S. (2001) Prognostic significance of combined conventional and immunocytochemical cytology for peritoneal washings in endometrial carcinoma. Cancer 93, 115-123. Lurain JR, Rice BL, Rademaker AW, Poggensee LE, Schink JC, Miller DS. (1991) Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 78, 63-69. MacDonald RR, Thorogood J, Mason MK. (1988) A randomized trial of progestogens in the primary treatment of endometrial carcinoma. Br J Obstet Gynaecol. 95, 166-174. Maggi R, Cagnazzo G, Atlante G, Marinaccio M. (1999) Risk groups and adjuvant therapy in surgical staged endometrial cancer patients. A randomized multicentre study comparing chemotherapy with radiation therapy. In: "7th Biennial Meeting of the International Gynecologic Cancer Society" Rome (Italy), September 26-30, 1999 (Pecorelli S, Atlante G, Benedetti Panici P, Mancuso S Eds) Monduzzi Editore, International Proceedings Division, 97-101. Maggino T, Romagnolo C, Zola P, Sartori E, Landoni F, Gadducci A. (1995) An analysis of approaches to the treatment of endometrial cancer in western Europe: a CTF study. Eur J Cancer. 31A, 1993-1997. Malkasian GD jr, Decker DG. (1978) Adjuvant progesterone therapy for stage I endometrial carcinoma. Int J Gynaecol Obstet 16, 48-49. Malur S, Possover M, Michels W, Schneider A. (2001) Laparoscopic-assisted vaginal versus abdominal surgery in patients with endometrial cancer--a prospective randomized trial. Gynecol Oncol 80, 239-244.
388